FDA approves Blenrep for relapsed or refractory a number of myeloma
The U.S. Meals and Drug Administration authorized Blenrep (belantamab mafodotin-blmf) together with…
Novel CAR-T remedy achieves constructive ends in a excessive proportion of sufferers with a refractory sort of lymphoma
Dr. Javier Briones, researcher at Sant Pau Analysis Institute (IR Sant Pau)…
Researchers reveal dangers of tisa-cel remedy for relapsed or refractory B-cell lymphomas
Laryngeal edema is a extreme adversarial impact of CAR T-cell remedy in…
